Contact Us

SEC Filings

Investor Contacts

Jeff Macdonald
Executive Director,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717

SEC Filings

Filing date	Form	Description	Filing Group	View
Dec 30, 2009	EFFECT	EFFECT	Other	View HTML 9999999995-09-003647.pdf 9999999995-09-003647.rtf
Dec 29, 2009	CORRESP	CORRESP	Other	View HTML 0001193125-09-261064.pdf 0001193125-09-261064.rtf 0001193125-09-261064.xls
Dec 23, 2009	S-1	Registration statement for face-amount certificate companies	Registration Statements	View HTML 0001193125-09-259428.pdf 0001193125-09-259428.rtf 0001193125-09-259428.xls
Dec 23, 2009	S-1/A	Amended Registration statement for face-amount certificate companies	Registration Statements	View HTML 0001193125-09-259439.pdf 0001193125-09-259439.rtf 0001193125-09-259439.xls
Dec 22, 2009	UPLOAD	UPLOAD	Other	View HTML 0000000000-09-072060.pdf
Dec 11, 2009	10-K/A	Amendment to a previously filed 10-K	Annual Filings	View HTML 0001193125-09-251555.pdf 0001193125-09-251555.rtf 0001193125-09-251555.xls
Dec 11, 2009	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	View HTML 0001193125-09-251559.pdf 0001193125-09-251559.rtf 0001193125-09-251559.xls
Dec 11, 2009	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	Registration Statements	View HTML 0001193125-09-251568.pdf 0001193125-09-251568.rtf 0001193125-09-251568.xls
Dec 09, 2009	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001232524-09-000032.pdf 0001232524-09-000032.rtf
Dec 09, 2009	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0001232524-09-000031.pdf 0001232524-09-000031.rtf

Data provided by Kaleidoscope.